Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

100
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
100

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organoids in Haematologic Research: Advances and Future Directions.

Cell proliferation·2025
Same author

Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.

Nature·2024
Same author

Human organoid models to study SARS-CoV-2 infection.

Nature methods·2022
Same author

SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence.

Research square·2021
Same author

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.

Nature·2020
Same author

In Vivo Wound Healing Activity of <i>Abrus cantoniensis</i> Extract.

Evidence-based complementary and alternative medicine : eCAM·2017

Related Experiment Video

Updated: May 6, 2026

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
10:30

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

35.1K

Organoid Models to Study Human Infectious Diseases.

Sijing Zhu1,2,3,4, Dan Chen1,2,3,4, Xinzhi Yang1,2,4

  • 1Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Cell Proliferation
|February 20, 2025
PubMed
Summary

Organoid models offer a powerful tool for studying infectious diseases like HIV, Zika, SARS-CoV-2, and Mpox. This research explores their use in understanding viral mechanisms and developing new treatments.

Keywords:
drug screeninginfectious diseaseorganoidsvirus

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens
10:59

Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens

Published on: May 12, 2019

9.7K
Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
07:59

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions

Published on: September 10, 2021

3.0K

Related Experiment Videos

Last Updated: May 6, 2026

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
10:30

Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori

Published on: November 12, 2015

35.1K
Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens
10:59

Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens

Published on: May 12, 2019

9.7K
Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
07:59

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions

Published on: September 10, 2021

3.0K

Area of Science:

  • Infectious Disease Research
  • Biomedical Science
  • Organoid Technology

Background:

  • Infectious diseases pose significant global health and economic threats.
  • Organoids mimic human physiology, offering advantages for disease research.
  • Historical outbreaks have advanced understanding of viral infections, prevention, and treatment.

Purpose of the Study:

  • To review the development and application of organoids in infectious disease research.
  • To focus on significant viral diseases including HIV, ZIKV, SARS-CoV-2, and MPXV.
  • To explore organoid utility in understanding pathogenesis, host response, and therapeutics.

Main Methods:

  • Review of organoid development and applications in virology.
  • Analysis of research utilizing organoid models for specific infectious diseases.
  • Synthesis of current techniques and future prospects in organoid-based research.

Main Results:

  • Organoids provide a versatile platform for studying viral pathogenic mechanisms.
  • Organoid models facilitate research into host-pathogen interactions and therapeutic strategies.
  • Integration of advanced techniques enhances organoid capabilities for infectious disease modeling.

Conclusions:

  • Organoids represent a promising avenue for advancing vaccine and drug development against infectious diseases.
  • Continued innovation in organoid technology will be crucial for combating future viral threats.
  • Organoid research offers significant advantages in availability, editability, and diversity for studying viral infections.